EC approves Xofigo from Bayer, Algeta

The European Commission approved an MAA from Bayer AG (Xetra:BAYN) for Xofigo radium-223 dichloride to treat adults with castration-resistant prostate cancer (CRPC), symptomatic bone metastases and no...